Clinical Trial Update: Cardiovascular Effects of Empagliflozine [NA]

View source ↗

Summary

A clinical trial update on the cardiovascular effects of empagliflozin in people with type 2 diabetes, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)

Snippet

Sponsor: Tel Aviv University | Conditions: Type 2 Diabetes | NA | Status: UNKNOWN